Answers are grounded in this paper and cite their sources.
The efficacy and safety of alirocumab and evolocumab in routine clinical practice are consistent with the findings of the pivotal clinical trials.
No takes yet. Share an insight, caveat, or question.
Blanco‐Ruiz et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: